Aggressive Variant Prostate Carcinoma
3 clinical trials · Condition
◉ Watch Aggressive Variant Prostate Carcinoma
| Record | Firm | Date |
|---|---|---|
| Cabazitaxel, Carboplatin, and Cetrelimab Followed by Niraparib With or Without Cetrelimab for the Treatment of Aggressive Variant Metastatic Prostate Cancer (NCT04592237) | M.D. Anderson Cancer Center | 2020-12-29 |
| DS3201 and Ipilimumab for the Treatment of Metastatic Prostate, Urothelial and Renal Cell Cancers (NCT04388852) | M.D. Anderson Cancer Center | 2020-08-20 |
Track Aggressive Variant Prostate Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.